| Literature DB >> 25166283 |
Amelia C Peterson1, Allison J Balloon, Michael S Westphall, Joshua J Coon.
Abstract
Identification of unknown peaks in gas chromatography/mass spectrometry (GC/MS)-based discovery metabolomics is challenging, and remains necessary to permit discovery of novel or unexpected metabolites that may elucidate disease processes and/or further our understanding of how genotypes relate to phenotypes. Here, we introduce two new technologies and an analytical workflow that can facilitate the identification of unknown peaks. First, we report on a GC/Quadrupole-Orbitrap mass spectrometer that provides high mass accuracy, high resolution, and high sensitivity analyte detection. Second, with an "intelligent" data-dependent algorithm, termed molecular-ion directed acquiEntities:
Mesh:
Year: 2014 PMID: 25166283 PMCID: PMC4204910 DOI: 10.1021/ac5014755
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986
Figure 1Typical MIDA-MS/MS with metabolic labeling data. (A) Partial MS spectrum showing [M – t-butyl]+, [M – CH3]+, [M + H]+, and methane PCI adduct ions (unlabeled) for asparagine – 3TBS under four different metabolic labeling states. Comparison of the m/z shifts of similar ions between the four states allows assignment of the number of carbons and nitrogens in each ion. (B) Profiles of the MIDA-MS/MS of [M–CH3]+ over the entire elution profile of asparagine – 3TBS for all four labeling states. (C) MS/MS of asparagine – 3TBS [M–CH3]+ ion from all four labeling states. Comparison of the m/z shifts of similar ions between the four spectra allows assignment of the number of carbon and nitrogen in each fragment ion. Above, structures proposed using the knowledge of the number of carbons and nitrogens (shown as red circles or red letters, respectively) for eight ions in the MS/MS spectrum. The MS/MS spectrum confirms the structure of asparagine – 3TBS.
Figure 2Workflow for spectral annotation and structural confirmation. From top to bottom, first, the ion type selected by MIDA for MS/MS, the m/z, the abundance of the first–third isotopomers, and the number of carbons and nitrogens present are noted from the MS spectrum. Candidate formulas are then generated within ±5 ppm tolerance of the neutralized mass of the ion and filtered for Si to result in a list of 21 formulas (out of 41). Candidates are submitted for filtering by the Seven Golden Rules with a 15% isotopomer abundance error (IAE) threshold. All 21 formulas meet the 15% threshold, 14 meet a 10% threshold, 7 at 5%, 3 at 2%, and 1 at 1%. All formulas meeting the 15% threshold are made intact by addition of C4H8, a t-butyl group (shown in the second level under the formulas meeting the 2% IAE threshold). Silylation groups are removed from the intact formulas, as shown in the third level under the formulas meeting the 2% IAE threshold. The desilylated formulas are refiltered by the Seven Golden Rules. The six formulas present in PubChem are further filtered by the number of nitrogen and carbon present in the analyte (four carbons and one nitrogen) to yield a single formula, C4H7NO4, which is confirmed using the MS/MS spectrum, and tentatively identified as aspartate – 3TBS.
Selected Compounds Tentatively Identified by Our Workflow in Methane PCI with TMS Derivatization Analyses Showing the Reduction of Candidates with Each Filtering Step (See Figure 2)
| ion | no. C | no. N | MS/MS | no. by mass | no. Pub Chem | no. N and no. C | native formula | proposed
ID | veri-fied | mass error (ppm) | avg IAE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [M – CH3]+ | 174.0584 | 3 | 0 | × | 1 | 1 | 1 | C3H4O3 | pyruvic acid TMS MOX | × | 4.5 | 1.7 |
| [M – CH3]+ | 234.1161 | 0 | 0 | × | 10 | 1 | 1 | H3NO | hydroxylamine 3TMS | – | 4.3 | 1.2 |
| [M – CH3]+ | 218.1028 | 3 | 1 | × | 2 | 1 | 1 | C3H7NO2 | alanine 2TMS | × | 4.8 | 1.2 |
| [M + H]+ | 235.0818 | 2 | 0 | – | 9 | 2 | 1 | C2H2O4 | oxalic acid 2TMS | × | –0.8 | 8.0 |
| [M + H]+ | 176.0741 | 2 | 0 | – | 3 | 0 | 1 | C2H2O3 | glyoxylic acid TMS MOX | × | –1.8 | 3.1 |
| [M – CH3]+ | 220.0822 | 1 | 0 | × | 2 | 0 | 1 | CH2O3 | carbonic acid 2TMS MOX | – | 4.0 | 1.5 |
| [M + H]+ | 262.1655 | 5 | 1 | × | 6 | 2 | 1 | C5H11NO2 | valine 2TMS | × | –0.6 | 1.3 |
| [M – CH3]+ | 189.0873 | 1 | 2 | × | 5 | 3 | 1 | CH4N2O | urea 2TMS | × | 6.0 | 2.0 |
| [M – CH3]+ | 179.0524 | 7 | 0 | × | 3 | 2 | 1 | C7H6O2 | benzoic acid TMS | × | 5.4 | 1.6 |
| [M – CH3]+ | 262.1471 | 2 | 1 | × | 4 | 2 | 1 | C2H7NO | ethanolamine 3TMS | × | 4.9 | 1.6 |
| [M + H]+ | 315.1026 | 0 | 0 | × | 29 | 7 | 1 | H3O4P | phosphate 3TMS | × | 0.5 | 0.7 |
| [M – CH3]+ | 260.1499 | 6 | 1 | × | 4 | 2 | 1 | C6H13NO2 | leucine 2TMS | × | 3.4 | 4.7 |
| [M – CH3]+ | 293.1419 | 3 | 0 | × | 9 | 3 | 1 | C3H8O3 | glycerol 3TMS | × | 3.7 | 2.0 |
| [M + H]+ | 276.1814 | 6 | 1 | × | 6 | 2 | 1 | C6H13NO2 | isoleucine 2TMS | × | –1.7 | 2.3 |
| [M + H]+ | 196.0790 | 6 | 1 | – | 2 | 2 | 1 | C6H5NO2 | nicotinic acid TMS | × | –0.9 | 2.5 |
| [M – CH3]+ | 244.1182 | 5 | 1 | × | 3 | 1 | 1 | C5H9NO2 | proline 2TMS | × | 5.0 | 1.2 |
| [M – CH3]+ | 245.0660 | 4 | 0 | – | 7 | 2 | 1 | C4H4O4 | maleic acid 2TMS | × | 4.5 | 2.0 |
| [M – CH3]+ | 276.1262 | 2 | 1 | × | 17 | 8 | 1 | C2H5N02 | glycine 3TMS | × | 5.3 | 5.7 |
| [M – CH3]+ | 247.0818 | 4 | 0 | × | 7 | 2 | 1 | C4H6O4 | succinic acid 2TMS | × | 3.9 | 1.2 |
| [M – CH3]+ | 307.1209 | 3 | 0 | × | 18 | 4 | 1 | C3H6O4 | glyceric acid 3TMS | – | 4.5 | 0.8 |
| [M – CH3]+ | 245.0657 | 4 | 0 | × | 19 | 5 | 1 | C4H4O4 | fumaric acid 2TMS | × | 5.5 | 1.4 |
| [M – CH3]+ | 306.1372 | 3 | 1 | × | 10 | 3 | 1 | C3H7NO3 | serine 3TMS | × | 3.4 | 1.2 |
| [M – CH3]+ | 320.1530 | 4 | 1 | × | 13 | 3 | 1 | C4H9NO3 | threonine 3TMS | × | 2.7 | 1.1 |
| [M – CH3]+ | 320.1534 | 4 | 1 | × | 27 | 7 | 1 | C4H9NO3 | allothreonine 3TMS | – | 1.5 | 8.6 |
| [M – CH3]+ | 349.1316 | 5 | 0 | – | 32 | 9 | 1 | C5H8O5 | citramalic acid 3TMS | – | 3.5 | 13.4 |
| [M – CH3]+ | 335.1159 | 4 | 0 | × | 29 | 7 | 1 | C4H6O5 | malate 3TMS | × | 3.9 | 0.9 |
| [M – CH3]+ | 267.0865 | 7 | 0 | – | 10 | 1 | 1 | C7H6O3 | hydroxybenzoic acid 2TMS | – | 4.8 | 7.4 |
| [M + H]+ | 350.1633 | 4 | 1 | × | 23 | 7 | 1 | C4H7N04 | asparti acid 3TMS | – | 0.3 | 0.5 |
| [M + H]+ | 274.1290 | 5 | 1 | × | 7 | 2 | 1 | C5H7NO3 | pyroglutamic acid 2TMS | × | –0.4 | 0.9 |
| [M – CH3]+ | 332.1531 | 5 | 1 | – | 15 | 4 | 1 | C5H9NO3 | hydroxyproline 3TMS | × | 2.4 | 10.2 |
| [M – CH3]+ | 304.1574 | 4 | 1 | × | 21 | 7 | 1 | C4H9NO2 | 4-aminobutyric acid 3TMS | × | 5.1 | 1.0 |
| [M – CH3]+ | 322.1135 | 3 | 1 | – | 44 | 11 | 1 | C3H7NO2S | cysteine 3TMS | × | 6.0 | 15.9 |
| [M – CH3]+ | 409.1717 | 4 | 0 | – | 66 | 18 | 1 | C4H8O5 | threonic acid 4TMS | – | 1.6 | 1.8 |
| [M – CH3]+ | 333.1844 | 5 | 2 | × | 14 | 5 | 1 | C5H12N2O2 | ornithine 3TMS | – | 3.3 | 0.4 |
| [M – CH3]+ | 348.1473 | 5 | 1 | × | 24 | 7 | C5H9NO4 | glutamic acid 3TMS | × | 4.4 | 0.9 | |
| [M + H]+ | 310.1649 | 9 | 1 | × | 10 | 2 | 1 | C9H11NO2 | phenylalanine 2TMS | × | 1.5 | 1.1 |
| [M – CH3]+ | 333.1483 | 4 | 2 | × | 20 | 7 | 1 | C4H0N2O3 | asparagine 3TMS | × | 2.5 | 0.7 |
| [M – CH3]+ | 419.2037 | 5 | 2 | × | 56 | 13 | 1 | C5H10N2O3 | glutamine 4TMS | – | 1.5 | 0.4 |
| [M – CH3]+ | 361.2346 | 4 | 2 | – | 15 | 6 | 1 | C4H12N2 | putrescine 4TMS | – | 1.7 | 6.7 |
| [M + H]+ | 436.1638 | 6 | 0 | × | 189 | 1 | 1 | C6H6O7 | 2-oxalosuccinic acid 3TMS MOX | – | 0.0 | 1.7 |
| [M – CH3]+ | 347.1630 | 5 | 2 | × | 47 | 12 | 1 | C5H10O5 | glutamine 3TMS | × | 5.2 | 0.8 |
| [M – CH3]+ | 447.1869 | 7 | 0 | – | 104 | 22 | 1 | C7H10O5 | shikimic acid 4TMS | – | 2.5 | 5.5 |
| [M – CH3]+ | 465.1604 | 6 | 0 | × | 157 | 23 | 1 | C6H8O7 | citrate 4TMS | × | 3.8 | 0.5 |
| [M – CH3]+ | 358.1801 | 6 | 3 | × | 17 | 6 | 1 | C6H11N3O2 | arginine[-NH3] 3TMS | – | 2.0 | 2.3 |
| [M – CH3]+ | 422.1499 | 6 | 0 | × | 75 | 1 | 1 | C6H8O8 | 2-(Glycoloyloxy)succinic acid 3TMS MOX | – | –1.7 | 1.4 |
| [M + H]+ | 229.1163 | 10 | 2 | – | 6 | 1 | 1 | C10H8N2 | beta-indole-3-acetonitrileTMS | – | –3.1 | 4.5 |
| [M – CH3]+ | 431.1779 | 4 | 4 | × | 86 | 19 | 1 | C4H6N4O3 | allantoin 4TMS | – | 2.9 | 1.0 |
| [M – CH3]+ | 356.1639 | 6 | 3 | – | 23 | 7 | 1 | C6H9N3O2 | histidine 3TMS | – | 3.5 | 6.2 |
| [M + H]+ | 363.2314 | 6 | 2 | × | 17 | 5 | 1 | C9H14N2O2 | lysine 3TMS | × | –0.2 | 5.0 |
| [M – CH3]+ | 382.1687 | 9 | 1 | × | 35 | 7 | 1 | C9H11NO3 | tyrosine 3TMS | – | 2.2 | 1.7 |
| [M – CH3]+ | 449.1660 | 6 | 0 | × | 127 | 22 | 1 | C6H8O6 | ascorbic acid 4TMS | – | 2.9 | 4.3 |
| [M – CH3]+ | 435.1870 | 6 | 0 | – | 90 | 19 | 1 | C6H10O5 | 1,6-anhydroglucose 4TMS | – | 2.3 | 0.9 |
| [M + H]+ | 613.3080 | 6 | 0 | – | 384 | 45 | 1 | C6H12O6 | inositol 6TMS | – | –0.2 | 7.8 |
| [M – CH3]+ | 441.1623 | 5 | 4 | – | 109 | 31 | 1 | C5H4N4O3 | uric acid 4TMS | – | 2.7 | 3.2 |
| [M + H]+ | 421.2159 | 11 | 2 | × | 55 | 11 | 1 | C11H12N2O2 | tryptophan 3TMS | – | –0.4 | 5.6 |
| [M – CH3]+ | 353.1238 | 11 | 0 | × | 41 | 9 | 1 | C11H12O5 | sinapic acid 2TMS | – | 2.1 | 1.4 |
MIDA-MS/MS data was acquired on the [M–CH3]+ of the analyte.
Number of elemental formulas within ±5–10 ppm of the neutralized measured mass.
Number of elemental formulas present in PubChem after filtering by the Seven Golden Rules, accounting for fragmentation, removing TMS group, and refiltering by the Seven Golden Rules.
Number of elemental formulas remaining after constraining the formulas present in PubChem by the number of carbons and nitrogen in the native analyte.
Assigned elemental formula for the native analyte.
Proposed identification of the assigned elemental formula based on metabolites expected in A. thaliana.
Metabolites verified with authentic standards (see Figure S3 in the Supporting Information).
Figure 3Relative quantification with MIDA-SIM. Accuracy and precision of quantification for dilution of the 13C14N sample into the 12C14N sample relative to a 1:1 mix. Data from 28 features extracted from EI full scan or EI MIDA-triggered SIM data are shown in black and red, respectively. The improvement of S/N with use of MIDA-SIM enhances quantification accuracy and precision. The target ratio at each dilution is denoted by a dotted gray line.